zimberelimab   Click here for help

GtoPdb Ligand ID: 12349

Synonyms: AB-122 | AB122 | GLS-010
Approved drug Immunopharmacology Ligand
zimberelimab is an approved drug (China (2021))
Compound class: Antibody
Comment: Zimberelimab (AB-122, GLS-010) a fully human, IgG4λ anti-programmed cell death protein-1 (PD-1) monoclonal antibody [1]. It is an immune checkpoint inhibitor class immuno-oncology therapeutic.
Click here for help
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes (China (2021))
Approved drug? Yes. China (2021)
International Nonproprietary Names Click here for help
INN number INN
11413 zimberelimab
Synonyms Click here for help
AB-122 | AB122 | GLS-010
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1071
Other databases
GtoPdb PubChem SID 479821140
Search PubMed clinical trials zimberelimab
Search PubMed titles zimberelimab
Search PubMed titles/abstracts zimberelimab